* D-Serine modulates N-methyl D-aspartate receptors (NMDARs) and regulates synaptic plasticity, neurodevelopment, and learning and memory. However, the primary site of D-serine synthesis and release remains controversial, with some arguing that it is a gliotransmitter and others defining it as a neuronal cotransmitter. Results from several laboratories using different strategies now show that the biosynthetic enzyme of D-serine, serine racemase (SR), is expressed almost entirely by neurons, with few astrocytes appearing to contain D-serine. Cellselective suppression of SR expression demonstrates that neuronal, rather than astrocytic D-serine, modulates synaptic plasticity. Here, we propose an alternative conceptualization whereby astrocytes affect D-serine levels by synthesizing Two different strategies are commonly used to determine the roles played by glycine-B site agonists. First, in electrophysiological studies, the extracellular agonists can be selectively eliminated by perfusing slices with purified D-amino acid oxidase (DAO) to degrade D-serine or purified glycine oxidase (GO) to eliminate glycine [3,[6][7][8][9]. Using this strategy, D-serine was shown to be the primary NMDAR co-agonist required for long-term potentiation (LTP) at the hippocampal Schaffer collateral-CA1 pyramidal neuron synapse [8][9][10][11]. A more specific approach is to genetically silence SR expression. SRÀ/À mice have a 90% decrease in brain D-serine and show reduced NMDAR currents, impaired synaptic plasticity, and learning deficits, consistent with NMDAR hypofunction [12][13][14]. Importantly, the SRÀ/À phenotype, including deficits in LTP and fear-conditioned learning, is reversed by restoring brain D-serine [14], strengthening the notion that D-serine is critical to forebrain NMDAR function. Neuronal SR deletion impairs NMDAR function and synaptic plasticity, while astrocytic SR deletion has no effect.
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